실적분석 2026년 8월 20일

Flowers Foods ($FLO) FY2026 Q2 Earnings Analysis — Misses on Revenue and Adjusted EPS, Cuts Full-Year Outlook

Earnings Scorecard

Revenue: $1.193 billion (down 4.0% YoY, vs. $1.235 billion estimate) ❌ Miss

EPS: Adjusted $0.21 (vs. $0.22 estimate) ❌ Miss

Guidance: Lowered — FY2026 adjusted EPS $0.75–$0.85 (prior $0.80–$0.90), revenue approximately $5.070 billion–$5.142 billion

Stock reaction: Extended hours -5.49% ($6.71) — as of 06:00 KST, Aug 21

What Went Well

Price/mix: Up 1.8% YoY, reflecting improved pricing and mix

Easing input costs: Commodity cost pressure eased, relieving cost burdens

Nature's Own relaunch: Strong early customer and retail feedback, strengthening the health-oriented positioning

Price increases and product-mix improvement partially offset the volume decline, and interest expense also fell as debt was reduced. However, the relaunch is still in its early stages, so its earnings contribution remains limited.

What Fell Short

Volume: Total volume -5.8%, with branded retail down a steeper -7.6%

Sharp profit drop: Adjusted net income -30.5%, adjusted EBITDA -19.2%

Full-year guidance cut: Revenue, adjusted EPS, and adjusted EBITDA all lowered

Demand for fresh packaged bread was weak amid macroeconomic pressure and competition, compounded by higher labor, transportation, and marketing costs. As margins compressed, the bar for the second half was lowered accordingly.

What Management Said

Management acknowledged that fresh packaged bread category conditions were tougher than expected, explaining that the full-year outlook was revised conservatively to reflect first-half results and the current environment. The company expressed its intent to strengthen medium- and long-term competitiveness through the Nature's Own relaunch and organizational and cost restructuring, but signals of a near-term recovery remain weak.

Market Reaction and What to Watch Next

The miss on both revenue and earnings, combined with a lowered full-year guide, triggered a sell-the-news response.

Monitor whether the decline in branded retail volume narrows in the next quarter.

Watch when the Nature's Own relaunch begins to meaningfully contribute to revenue.

The key focal point is whether the company can defend the low end of the full-year adjusted EPS range of $0.75.